Adtalem Global Education (NYSE:CVSA) Issues Earnings Results

Adtalem Global Education (NYSE:CVSA) released its earnings results on Thursday. The company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25, FiscalAI reports. The company had revenue of $487.03 million for the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 19.98%. Adtalem Global Education’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the company posted $1.92 earnings per share. Adtalem Global Education updated its FY 2026 guidance to 7.950-8.150 EPS.

Adtalem Global Education Trading Up 13.4%

NYSE:CVSA traded up $15.68 during trading hours on Friday, hitting $132.68. The stock had a trading volume of 702,974 shares, compared to its average volume of 275,810. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.68 and a current ratio of 0.68. Adtalem Global Education has a 1-year low of $86.97 and a 1-year high of $156.26. The firm has a 50 day simple moving average of $110.78. The company has a market capitalization of $4.58 billion, a P/E ratio of 20.67, a PEG ratio of 0.99 and a beta of 0.63.

Insider Transactions at Adtalem Global Education

In other news, Director Michael W. Malafronte acquired 8,890 shares of the stock in a transaction on Wednesday, March 11th. The stock was bought at an average price of $100.94 per share, with a total value of $897,356.60. Following the completion of the transaction, the director directly owned 25,395 shares of the company’s stock, valued at $2,563,371.30. The trade was a 53.86% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders have purchased a total of 37,236 shares of company stock valued at $3,752,866 over the last three months. 2.50% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on CVSA shares. Zacks Research downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Truist Financial started coverage on shares of Adtalem Global Education in a research note on Tuesday, March 24th. They set a “buy” rating and a $130.00 price objective for the company. Wall Street Zen downgraded shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday. Barrington Research reissued an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research report on Friday, April 17th. Finally, Weiss Ratings initiated coverage on shares of Adtalem Global Education in a research report on Wednesday, February 25th. They set a “hold (c+)” rating for the company. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Adtalem Global Education currently has an average rating of “Moderate Buy” and a consensus target price of $150.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.